Tocotrienols of palm oil have been shown to possess potent neuroprotective, antioxidative, anticancer, and cholesterollowering activities. In this study, the authors examined the antiproliferative effects of a-, gand d-tocotrienols (aT3, gT3, and dT3), and a-tocopherol (aT) in human cervical carcinoma (HeLa) cells. Their mechanism(s) of action on cell cycle signaling pathway were also investigated. Results showed that the antiproliferative effect of aT3 (IC 50 : 3.19 ± 0.05 mM) and gT3 (IC 50 : 2.85 ± 0.07 mM) was more potent than dT3 (IC 50 : >100 mM) and aT (IC 50 : 69.46 ± 3.01 mM). Both aT3 and gT3 also demonstrated a dose-dependent and time-dependent induction of cell death. They caused cell cycle arrest at G2/M phase and triggered apoptosis as displayed by the externalization of annexin V-targeted phosphatidylserine and accumulation of sub-G1 peak. At a concentration of 3 mM, aT3 downregulated the expression of cyclin D3, p16, and CDK6, while having no effect on cyclin D1, p15, p21, p27, and CDK4 expression. However, gT3 showed no effect on these proteins. The induction of HeLa cell apoptosis by aT3 and gT3 appeared to be associated with the expression of IL-6, but not the other cytokines (IFN-g, IL-2, and IL-10). Taken together, the results suggest that aT3 and gT3 are more effective than dT3 and aT in inhibiting HeLa cell proliferation, and their mode of action could be through the upregulation of IL-6, and the downregulation of cyclin D3, p16, and CDK6 expression in the cell cycle signaling pathway.
Introduction
Tumorigenesis encompasses multiple processes involving the dysregulation of a number of molecular pathways, such as cell cycle proliferation, angiogenesis, and apoptosis. The strategy of chemotherapy is based on the use of chemicals to retard cell cycle progression, inhibit angiogenesis, and induce apoptosis. Many anticancer agents have been shown to interfere with the cell cycle machinery, which is largely governed by a family of cyclin-dependent kinases (CDKs). 1, 2 The cyclins, members of the cell cycle regulators, bind to and activate CDKs. D-type cyclins such as cyclins D1, D2, and D3 accumulate in the G1 phase and contribute to the promotion of G1-S progression. 3, 4 The progression of cell cycle through G1 is mediated by cyclin D isoforms and CDK2, CDK4, and CDK6. 5, 6 Previous studies have indicated that D-type cyclins play an important role in tumorigenesis; overexpression of cyclin D1 was found in melanoma, breast, colon, and thyroid cancers. [7] [8] [9] [10] [11] CDKs can be inhibited by 2 classes of CDK inhibitors, the INK4 class (p15 Ink4b or p16 Ink4a ) and the CIP/KIP class (p21 waf1 or p27 kip1 ). 6, 12, 13 Epidemiologic and laboratory studies have shown that cervical cancer often arises from human papillomaviral infections. [14] [15] [16] It was also found to develop in close association with chronic inflammation caused by various sexually transmitted agents. 17 Interleukin-6 (IL-6), a central proinflammatory cytokine, is believed to play an important role in the pathogenesis of cervical cancer. It is also known to be involved in a variety of biological processes, including the immune response, inflammation, and regulating cell growth, survival, and differentiation. 18 The vitamin E family consists of 2 subgroups, namely tocopherols and tocotrienols, which exist in nature as a, b, g, and d forms. The 2 differ structurally in that tocopherols contain a saturated phytyl chain, and tocotrienols possess an unsaturated side chain attached to 1-position on the chroman ring. In previous studies, tocotrienols and tocotrienolrich fraction (TRF) from palm oil have demonstrated inhibition of the growth of breast, [19] [20] [21] colon, 22 prostate, 23 liver, 24 and gastric 25 cancer cells. Studies also showed that tocotrienols possess more potent beneficial effects on neuroprotection, antioxidant and cholesterol lowering activities than tocopherols. [26] [27] [28] In this study, our objectives were (a) to evaluate the antiproliferative effects of tocotrienols (aT3, gT3, and dT3 forms) and a-tocopherol (commonly known as vitamin E) on human cervical carcinoma (HeLa) cells, (b) to examine the effects of aT3 and gT3 on the cell cycle arrest and apoptotic induction, and (c) to examine the cell cycle signaling pathway and cytokine secretion (IFN-g, IL-2, IL-6, and IL-10) in HeLa cells.
Materials and Methods Chemicals
Minimum essential medium (MEM), d-a-tocopherol (aT), dimethyl sulfoxide (DMSO), penicillin, streptomycin, tryspin-EDTA, and anti-b-actin body were purchased from Sigma Chemical Company (St. Louis, MO). Fetal bovine serum (FBS) was obtained from GIBCO BRL (Gaithersburg, MD). The anti-p15, anti-p16, anti-p21, anti-p27, anti-CDK4, anti-CDK6, anti-cyclin D1, anticyclin D3, and anti-rabbit IgG bodies were purchased from Cell Signaling Technology Inc. (Danvers, MA). Anti-mouse IgG antibody was from Promega (Madison, WI). Tocotrienol isomers (aT3, gT3, and dT3) with a purity of 90% were kindly provided by Carotech Ltd. (Ipoh, Malaysia).
Cell Cultures
The HeLa cells (ATCC CCL-2) were obtained from the American Type Culture Collection (Rockville, MD) and were grown in 90% MEM supplemented with 10% FBS, 100 units/mL penicillin, and 100 mg/mL streptomycin. They were maintained at 37°C in a humidified atmosphere of 5% CO 2 .
Preparation of Test Solution
The stock solutions of various tocotrienol isomers were prepared in DMSO and were stored at -20°C until use. The concentrations used for the study were 1, 2, 3, and 5 mM, which were freshly prepared for each experiment with a final DMSO concentration of 0.1%.
MTT Assay for Cell Viability
Cytotoxicity studies were performed in 96-well plates. HeLa cells were cultured at 1 × 10 5 cells per well in 96-well plates containing 100 mL of MEM medium. After an overnight incubation, the test drug was added, and the plates were incubated for 24 hours. Cells were washed once before adding 50 mL of FBS-free medium containing MTT (5 mg/ mL). After 4 hours of incubation at 37°C, the medium was discarded and the formazan blue that formed in the cells was dissolved in DMSO. The measurement was conducted at a wavelength of 550 nm.
Detection of aT3and gT3-Induced Apoptosis
The annexin V-FITC Apoptosis Detection kit was used to label the externalized phosphatidylserine according to the manufacturer's protocol (Roche Diagnostics GmbH, Mannheim, Germany). The analysis was performed with a flow cytometer (BD FACS 101, Bedford, MA) equipped with a 488-nm argon laser. Approximately 10 000 cells were evaluated for each sample. Gating of control nonapoptotic populations (cells treated with 0.1% DMSO) was used as a reference to compare with aT3and gT3treated groups.
Cell Cycle Analysis
After 24 hours of incubation, cells were treated with 0.1% DMSO (control), 1, 3, and 5 mM of aT3 and gT3. Floating and adherent cells were then collected. The cells in suspension were fixed with 70% ice-cold methanol and then transferred to the freezer until use. After washing with PBS, cells were stained with 50 mg/mL propidium iodide (PI) in the presence of 25 mg/mL RNase A at 37°C for 30 minutes. A minimum of 10 000 cells per sample were collected. To estimate the percentage of each phase in cell cycle, the DNA histograms were analyzed by Multicycle software (Phoenix Flow Systems, San Diego, CA).
Western Immunoblot Analysis
Cells were harvested and lysed in ice-cold buffer (10 mM Tris-HCl, pH 7.5, 0.1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS (sodium dodecyl sulfate), 1 mM sodium orthovanate, and 120 mM sodium chloride) containing 1 mM phenylmethylsulfonyl fluoride, 10 mg/mL leupeptin, and 1 mg/mL aprotonin (Sigma Chemical Company, St. Louis, MO). Lysates were centrifuged at 10 000 × g for 10 minutes. Equal amounts of lysate protein (50 mg/lane) were loaded onto SDS-polyacrylamide gels and electrophoretically transferred to a PVDF (polyvinylidine difluoride) membrane in 5% (w/v) skim milk in PBST for 1 hour at room temperature. Antibody recognition was detected with the respective secondary antibody, either anti-mouse IgG or anti-rabbit IgG antibody linked to the horseradish peroxidase. Antibody-bound proteins were detected by the ECL Western blotting analysis system (Amersham, Aylesbury, UK). The expression of b-actin was used as a control.
Reverse Transcriptase-Polymerase Chain Reaction Analysis
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was used to examine the levels of IFN-g, IL-2, IL-6, and IL-10 mRNA expression. b-Actin was performed as a positive control. RNA was isolated with TRIzol reagent (Invitrogen, Carlsbad, CA). Aliquots (2 mg) of total RNA were reverse transcribed to complementary DNA (cDNA) using AMV reverse transcriptase. The primers used for PCR were as follows: 5′-ATGAAATATACAAGTTATATC TTGGCTTT-3′ and 5′-GATGCTCTTCGACC-CCTCGAA ACAGCAT-3′ for IFN-g mRNA, 5′-ATGTACAGGATG CAACTCCTGTC-TT-3′ and 5′-TCAGTGTTGAGATGAT GCTTTGAC-3′ for IL-2 mRNA, 5′-ATGAACT-CCTTCT CCACAAGCGC-3′ and 5′-GAAGAGCCCTCAGGCTG GACTG-3′ for IL-6 mRNA, and 5′-AAGCTGAGA AC CAAGACCCAGACATCAAGGCG-3′ and 5′-AGCT-ATCC CAGAGCCCCAGATCCGATTTTGG-3′ for IL-10 mRNA. PCR reaction mixtures (25 mL each) containing 10 mM Tris-HCl (pH 9.0), 1.5 mM MgCl 2 , 50 mM KCl, 0.2 mM dNTP, 1 mM of each primer, 0.25 unit Taq polymerase and cDNA templates were prepared. The cycling conditions were as follows: 28 cycles of 95°C for denaturation, 55°C for annealing, and 72°C for extension. A volume of 12 mL of each PCR product were analyzed on a 2% agarose gel and visualized under ultraviolet light by staining with ethidium bromide.
Statistical Analysis
Data were presented as mean ± standard deviation (mean ± SD) from 3 independent experiments. Values were evaluated by one-way analysis of variance (ANOVA), followed by Duncan's multiple range tests using the Statistical Analysis System (SAS Institute, Cary, NC). Differences were considered significant when P value was <.05.
Results

Tocotrienols (aT3, gT3, and dT3) and a-Tocopherol (aT) Induced Growth Inhibition on HeLa Cells
Results showed that both aT3 (IC 50 : 3.19 ± 0.05 mM) and gT3 (IC 50 : 2.85 ± 0.07 mM) possessed a lower IC 50 value than dT3 (IC 50 : >100 mM) and aT (IC 50 : 69.46 ± 3.01 mM) on cell cytotoxicity ( Table 1) , indicating that aT3 and gT3 were more potent in inhibiting HeLa cell proliferation. At concentrations of 1.0 to 5.0 mM, the antiproliferative effects of aT3 and gT3 on HeLa cells were noted to be in a dosedependent and time-dependent manner ( Tables 2 and 3 ). After 24 hours of treatment, 3 mM aT3 and 3 mM gT3 caused a 46.08% and 54.55% inhibition of cell growth, respectively, as compared with that of the control. Therefore, this concentration was used in all further mechanistic studies on the induction of aT3 and gT3 in HeLa cell death.
Tocotrienols-Induced Apoptosis
To further confirm the finding that aT3 and gT3 induced cell death, HeLa cells were stained with annexin V-FITC and PI, and subsequently analyzed by flow cytometry. As indicated by FACS (fluorescence activated cell sorting) analysis, the proportion of annexin V-stained cells was found to increase in aT3and gT3-treated cells ( Tables 4 and 5) .
HeLa cells treated with aT3 and gT3 exhibited a significant increase in the number of apoptotic cells.
Tocotrienols-Induced Cell Cycle Arrest
The effects of different concentrations (0, 1, 2, and 3 mM) of aT3 and gT3 on the cell cycle were determined by flow cytometry. Results showed that both aT3 and gT3 significantly induced cell cycle arrest in the G0/G1 phase and resulted in a dose-dependent decline in the percentage of cells in the S phase (Tables 6 and 7) .
Effects of Tocotrienols on the G1 Regulatory Proteins (Cyclin D1 and D3), and CDK4 and CDK6 Kinase Activity
To elucidate the mechanism(s) of cell cycle arrest in the aT3and gT3-treated cells, we analyzed the expression of G1 cyclins (cyclin D1 and cyclin D3), and CDK4 and CDK6 kinase activity at 0, 6, 12, and 24 hours after treatment. Results showed that aT3 time-dependently downregulated the protein expression of cyclin D3 and CDK6, but had no effect on cyclin D1 and CDK4 in HeLa cells (Figure 1 ). However, gT3 exhibited no effect on the expression of these proteins (Figure 2 ). The DNA content (sub-G1 peak) and the binding of annexin V-FITC to the plasma membrane were analyzed by flow cytometry. Values are mean ± SD of 3 independent experiments. Values within the same column with different superscript letters were significantly different at P < .05 as analyzed by Duncan's multiple range tests. 
Effects of Tocotrienols on the CDK Inhibitors, and INK4 (p15 Ink4b and p16 Ink4a ) and CIP/KIP (p21 waf1 and p27 kip1 ) Proteins
To determine the growth-inhibitory response of HeLa cells to aT3 and gT3 treatments, Western blot analysis was performed on p15, p16, p21, and p27 protein expression. As shown in Figure 1 , aT3 downregulated the level of p16 protein and had no effect on the expression of other CDK inhibitors. Surprisingly, no change in the expression of these proteins was noted with gT3 treatment.
Effects of Tocotrienols-Induction on Cytokine Formation
To determine the effects of aT3 and gT3 on the production of pro-inflammatory cytokines such as IFN-g, IL-2, IL-6, and IL-10, HeLa cells were treated with control (0.1% DMSO), aT3 and gT3 (1, 2, and 3 mM) for 24 hours and the cytokine secretion was measured by RT-PCR. Results showed that IL-6 production was markedly upregulated in both aT3and gT3-treated cells ( Figures 3A and 3B) . However, no response was noted on IFN-g, IL-2, and IL-10 in 1, 3, and 5 mM of aT3 and gT3 treatments (data not shown).
Discussion
This study has demonstrated that aT3, gT3, dT3, and aT possess a different magnitude of inhibitory effects on HeLa cell proliferation, and the order of potency was gT3 > aT3 > aT > dT3. Both aT3 and gT3 exerted inhibitory effect on the cell proliferation in a time-dependent and dose-dependent manner, with IC 50 values of 3.19 ± 0.05 mM and 2.85 ± 0.07 mM for aT3 and gT3, respectively. They induced cell cycle arrest at G0/G1 phase. Exposure of cells to aT3 and gT3 led to the degeneration of DNA as indicated by the appearance of sub-G1 population. After 24 hours of treatment, aT3 and gT3 caused cell apoptosis as demonstrated by the appearance of the phosphatidylserine on the cell surface. Chemotherapeutic and chemopreventive agents have been shown to impart antiproliferative effects via cell division arrest at certain checkpoints in the cell cycle. 23, 29 The control of cell cycle progression in cancer cells is considered to be an effective strategy for the control of tumor growth. 12, 30 Studies have shown that natural products such as statins were able to suppress the expression of cyclin D1, cyclin D3, CDK4, and CDK6, and caused an increase in the p21 and p27 expression. This phenomenon was noted on the G1 cell cycle arrest in prostate cancer cells. 31 In other studies, Tsai et al 32 reported that 15,16-dihydrotanshinone I reduced cyclin D1, cyclin D3, cyclin E, and CDK4 expression, and increased CDK inhibitor p27 expression in breast adenocarcinoma. Aggarwal and Ichikawa 33 demonstrated that indole-3-carbinol induced cell cycle arrest at the G1/S phase, upregulated p15, p21, and p27, and downregulated cyclin D1, CDK2, CDK4, and CDK6 in various cancer cells, including leukemic cells, breast, prostate, endometrial, and colon cancer cells. In this study, we showed that aT3 and gT3 caused cell cycle arrest at the G0/G1 phase in HeLa cells. aT3, but not gT3, significantly decreased the cyclin D3, p16, and CDK6 expression, while having no effect on cyclin D1, p15, p21, p27, and CDK6. However, gT3 exhibited no effect on the expression of these proteins. A previous study has demonstrated that gT3 inhibited the arrest of human gastric adenocarcinoma (SGC-7901) cell growth in the G0/G1 phase. 34 These results suggest that the effects of T3 on cell cycle distribution are dependent on cell cycle states and possibly cell types.
Epidemiologic and laboratory data suggest that cervical cancer typically arises from a series of causal steps including HPV (human papillomavirus) infections, oncogene expression (eg, c-Myc, Ha-Ras, and Erb-2) and/or upregulation of pro-inflammatory cytokines. [14] [15] [16] Previous investigations have demonstrated that IL-6 and its a-chain receptor are overexpressed in human cervical cancer tissues but not in the normal tissue. 35 IL-6, as a central proinflammatory cytokine, is known to be involved in female genital infection, and influence the pathogenesis of cervical cancer. 17 It was also found to be highly expressed in invasive cervical carcinoma, but is either not expressed or only barely expressed in the normal cervix or in preneoplastic lesions. 16 Overexpression of IL-6 has been shown to render cervical cancer cell apoptosis. 35 HeLa cells secreted no detectable levels of IL-1a, IL-18, or TNFa when incubated with Prevotella bivia for up to 20 hours. 36 In this study, both aT3and gT3-treated cells showed a marked upregulation of IL-6 production, while showing no effect on IFN-g, IL-2, and IL-10 expression, suggesting that aT3and gT3-induced cell apoptosis could be related to the upregulation of IL-6 expression.
Conclusion
In conclusion, we have demonstrated that both aT3 and gT3 possess potent antiproliferative activity in HeLa cells. They induced the cell cycle arrest in the G0/G1 phase and triggered cell apoptosis. Both aT3 and gT3 induced the increased release of IL-6 in HeLa cells. aT3, but not gT3, downregulated the expression of cyclin D3, p16, and CDK6 proteins. Taken together, the present study suggests that aT3 and gT3 are more effective than dT3 and aT in inhibiting HeLa cell proliferation, and their potential mechanism could be through the upregulation of IL-6 and the downregulation of cyclin D3, p16, and CDK6 expression in the cell cycle signaling pathway.
